0001209191-17-035160.txt : 20170524 0001209191-17-035160.hdr.sgml : 20170524 20170524200331 ACCESSION NUMBER: 0001209191-17-035160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170522 FILED AS OF DATE: 20170524 DATE AS OF CHANGE: 20170524 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17867968 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-22 0 0001625101 Pulse Biosciences, Inc. PLSE 0001055919 DUGGAN ROBERT W 611 S. FORT HARRISON AVE., SUITE 306 CLEARWATER FL 33756 0 0 1 0 Common Stock 2017-05-22 4 P 0 27928 26.149 A 3054244 D Common Stock 2017-05-22 4 P 0 6800 26.667 A 3061044 D Common Stock 2017-05-23 4 P 0 18600 26.688 A 3079644 D Common Stock 2017-05-23 4 P 0 28600 27.628 A 3108244 D Common Stock 2017-05-23 4 P 0 2000 28.074 A 3110244 D Common Stock 35000 I See footnote This is the weighted average purchase price of the shares, which ranged from $25.45 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $26.46 to $26.819 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $26.172 to $27.082 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $27.19 to $28.014 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $28.035 to $28.182 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary. Brian Dow, as Attorney-in-Fact for Robert W. Duggan 2017-05-24